In accordance with article 19 of Regulation (EU) No 596/2014, Solar is required to report share trading in Solar A/S of members of the Board of Directors, members of the Executive Board and related parties. The information in the below statement is based on reports from the above-mentioned persons to Solar. Name:Jesper Dalsgaard JensenReason:Vice-chair of the boardSecurities ID:DK0010274844 Solar BTransaction type:Purchase of sharesTransaction place:Nasdaq Copenhagen, DCSETransaction date:15 August 2025Tran ...

I think let's work for a sustainable negotiated agreement with the United States and I'm hopeful that we can achieve that. I think that we have to do with an administration in the US who is um trying to push us against the wall but at the same time these are our friends longstanding friends and therefore I'm confident that also at the G7 and thereafter we can find an a basis for uh the US to be and to continue to be a partner in security issues and we discuss it in NATO and on trade relations. Let's not loo ...

Core Viewpoint - cBrain has appointed Lars Møller Christiansen as the new CFO, effective August 1, 2025, succeeding Ejvind Jørgensen who has served for nine years [1][2]. Group 1: Leadership Transition - Lars Møller Christiansen will take over as CFO from Ejvind Jørgensen, who will remain with the company in a different capacity after a transition period [2]. - Ejvind Jørgensen has been with cBrain for nine years and will continue to be part of the company's journey [2]. Group 2: New CFO's Background - Lars Møller Christiansen has over 24 years of experience in the Danish government, focusing on financial management and digitization [3]. - He previously served as Deputy Director at the Environmental Protection Agency, where he was responsible for financial management and digitization [1][3]. - Lars is recognized as a digital front runner with extensive knowledge in eGovernment, which aligns with cBrain's international growth strategy [3]. Group 3: Vision and Goals - Lars emphasizes the importance of digital decision-making processes for accelerating the green transition and expresses enthusiasm for contributing to cBrain's climate and environmental goals [4].

Core Insights - Orion is hosting its Capital Markets Day on May 22, 2025, in Helsinki, focusing on its growth strategy and financial objectives without announcing new targets [1][5] - The company has three biologics assets in late research phases for immuno-oncology, with plans to initiate clinical phase I trials within the next 12 to 24 months [3][7] - Orion's Easyhaler® product portfolio for asthma and COPD is expected to exceed EUR 300 million in peak annual sales, driven by a shift towards dry-powder inhalers due to lower CO2 emissions [4][7] Company Overview - Orion is a Nordic pharmaceutical company with over a hundred years of experience, developing and marketing human and veterinary pharmaceuticals [6] - The company reported net sales of EUR 1,542 million in 2024 and employs approximately 3,700 professionals globally [6]